
and the World to China.
ACROSS Global AllianceTM.
Providing truly localized global
CRO solutions across the world.
and medical device companies
navigate the complex China market.
China-clinical

and the World to China.
ACROSS Global AllianceTM.
Providing truly localized global
CRO solutions across the world.
and medical device companies
navigate the complex China market.
China-clinical
Clinical Service Center (CSC) is a China-based clinical research outsourcing (CRO) company. Our goal is to help small-to-medium sized Western pharmaceutical, biotech and medical device companies bring their medical products to the China market by providing high-quality, cost-efficient in-China clinical-study and drug-development support services.

Here is how we can help you successfully navigate the China Medical Market
Medical & Clinical Strategy
Our team of highly trained physicians, pharmacologists, and statisticians can help you create a tailored clinical-development roadmap to get your product on the China market...
Regulatory
Affairs
We can guide you through the labyrinth of drug regulations and produce a submission-ready file to register your medical product with National Medical Products Administration (NMPA).
Clinical
Operations
We can assist you to identify the best Sites and Investigators for your study and provide proactive Project Management and Monitoring services from start to end with GCP and quality at the heart of everything we do.
Medical
Affairs
We can work with you to provide technical support, medical monitoring, pharmacovigilance, and formulate publication plans for journals and/or scientific meetings.
Data Management & Statistical Analysis
Our team of Data Management & Statistical experts are on hand to help collect and analysis your study data to global quality standards.
Site & Patient Management
Our SMO subsidiary can help provide Site Management and Patient Management services to ease the administrative burden on sites.
Investment/Partnership Database
China is home to the world’s second largest pharmaceutical market and many experts predict it will be number one over the coming years. For life-science investors, industry executives, pharmaceutical professionals and advisors looking for business opportunities in China, we can help you find the right solutions.
China Market Intelligence
INDUSTRY NEWS
Laboratory Fume Hoods Market Parallels Lab Construction, BioPharma Trends
Many chemical and biological processes of a laboratory’s work release hazardous gases into the air and protection for personnel and the lab environment is required. Aliquam non nulla nec odio pulvinar hendrerit quis at purus.

BLOG
Etiam lectus mauris, lobortis ac quam ac, dignissim pellentesque sapien. Aliquam non nulla nec odio pulvinar hendrerit quis at purus. In hac habitasse platea dictumst. Curabitur nec metus vitae tellus mattis rutrum.
Testimonials & Successes
At CSC we know China – Its people, culture, drug regulations, and the medical-market ecosystem. But being in a service industry, customer satisfaction is just as important as our deliverables. That’s why it’s of the utmost importance to everyone in our team to extend our non-negotiable commitment to quality over to our service quality, too. After all, word of mouth helped us get to where we are today, as did our high customer retention and referral rates.
More About the Clinical Service Center CRO
OUR LEADERSHIP TEAM
Our senior managers and executives were trained in the West, have worked for big Western pharmaceutical companies, and are committed to bringing the best clinical practices to China.
OUR HISTORY
For more than a decade, Clinical Service Center-“CSC” (formerly Beijing Clinical Service Center – “BCSC”) has been conducting top-quality clinical trial services in China for pharmaceutical, biotech, and medical device companies the world over.
FULL SERVICE PLUS
At CSC we define our business scope as “full-service plus” because we go above and beyond the requirements of a traditional full-service CRO to provide you with the end-to-end services you require to get your product in to the China market.